Date:3/2/2010

r3,prop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='85942202';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.cellulardynamics.com/about/management.html">Chris Parker, chief commercial officer of CDI and co-chairperson of the workshop.  "We organized this workshop, in collaboration with one of our customers, Roche, to present the iPSC-based cell model to the pharmaceutical toxicology community."

The presentation schedule:

• Human Inducible Pluripotent Stem Cell Derived In Vitro Models – the Path to a Better Understanding of Individual Biology and Their Utility in Drug Discovery and Development, Chris Parker, CDI, Madison, WI
• Application of Stem Cell-Derived Cardiomyocytes in Toxicology and Safety Pharmacology, Kyle Kolaja, Roche, Nutley, NJ
• Pharmaceutical Perspectives on Introduction of Regenerative Medicine Concepts into the Existing Pharmaceutical Paradigm, Ruth McKernan, Pfizer, Groton, CT
• Developing Stem Cell-Based Therapies: FDA Product and Preclinical Regulatory Considerations, Mercedes Serabian, U.S. FDA, Silver Spring, MD
• How the Understanding of the Biology of Inducible Pluri
  '/>"/>

SOURCE Cellular Dynamics International Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Intra-Cellular Therapies Provides Overview of its Proprietary Portfolio of Compounds for the Treatment of Female Sexual Dysfunction (FSD)
2. EpiCept to Present Pre-clinical Advances of Myc Oncogene Directed Drug Discovery at Assays and Cellular Targets Conference
3. National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications
4. Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
5. First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference
6. Cellular construction methods emulated
7. Having Penetrated Israels Domestic Telephony Market, 012 Smile.Communications Prepares for Its Next Goal: Entering Israels Cellular Market
8. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
9. New insights into cellular reprogramming revealed by genomic analysis
10. Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
11. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11